Sabaa Pharmaceutical's shareholders approve capital raise via bonus issue
Sabaa Pharmaceutical's profit leaps 76% in 2020 initial results
WHO ‘strongly’ against hydroxychloroquine use for COVID-19 prevention
https://english.mubasher.info/news/3789753/FRA-approves-Sabaa-Pharmaceutical-s-capital-raise/
© 2021 - 2024 All Rights Reserved. Designed & Developed By Spark Systems
